Infection latente a M. tuberculosis, mise a jour 2011 [Latent M. tuberculosis infection, update 2011].
Details
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_247DB65224E5
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Infection latente a M. tuberculosis, mise a jour 2011 [Latent M. tuberculosis infection, update 2011].
Journal
Revue Médicale Suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
2011
Peer-reviewed
Oui
Volume
7
Number
318
Pages
2289-2294
Language
french
Notes
Publication types: English Abstract ; Evaluation Studies ; Journal Article ; ReviewPublication Status: ppublish
Abstract
It is estimated that one third of the world population is latently infected by Mycobacterium tuberculosis and thus at risk of reactivation. Latent tuberculosis (TB) impact in Switzerland is often overlooked. Diagnosis and prophylaxis are insufficiently undertaken, especially for people at higher risk of reactivation due to immunosuppression. Interferon-gamma release assays replace tuberculosis skin tests for diagnosis of latent infection in adults. It is still recommended to treat prophylactically a case of latent TB infection with 9 months of isoniazid; however therapy with rifampicin for 4 months, currently an alternative option, is linked to improved adherence and favorable cost-benefit ratio.
Keywords
Adult, Health Care Costs, Hematologic Tests, Humans, Interferon-gamma Release Tests, Latent Tuberculosis/diagnosis, Latent Tuberculosis/economics, Models, Biological, Mycobacterium tuberculosis/isolation & purification, Tuberculin Test
Pubmed
Create date
31/05/2012 18:49
Last modification date
15/10/2024 6:26
Usage data
